SARS-CoV 2 Clinical Trial
Official title:
The Effects of Coronavirus on Perioperative Morbidity and Mortality in a High-risk Population: A Multicentre Cohort Study
In early 2020 the evolving COVID-19 Pandemic provided the world and medical community with a generational challenge. As a novel disease, countries were left with strategic decisions and many went into social lockdown. Initial resources and research were directed at upscaling internal medicine and intensive care services, understanding the disease pathophysiology, and testing treatments. It soon became evident that COVID-19 had multi-system effects at it's worst. In orthopaedics one of the most vulnerable groups to COVID-19 were the elderly, specifically those who suffered fractured neck of femur at this time. More literature is needed urgently if we are to understand and mitigate the negative impacts in this group of patients. This observational study assesses the early morbidity and mortality of patients with this diagnosis during the evolving COVID-19 Pandemic.
Many elderly patients admitted to hospitals during the evolving COVID-19 pandemic after falls
or being generally unwell, were considered to have a possible diagnosis of COVID-19. This was
extremely relevant to the subgroup of patients who suffered from fractured neck of femurs
during this time, with most of them elderly, frail, and more likely to have multiple
co-morbidities. COVID-19 was considered a precipitating factor for falls, but also
anecdotally, an indicator of potentially poor recovery and rehabilitation.
With regards to orthopaedic and trauma surgery, a limited amount of literature is available
pertaining to COVID-19 and specifically it's potential effects on patient outcomes in
patients requiring surgery.
We performed a multi centre observational study across London, United Kingdom, looking at the
demographics and details of patients admitted with fractured neck of femur during the
evolving pandemic. All data collected was non identifiable. Data was also collected as to the
COVID-19 status of these patients, either positive or negative. Data was analysed to assess
the morbidity and mortality of this patient group and search for any prognostic factors.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04410510 -
P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19
|
Phase 2/Phase 3 | |
Withdrawn |
NCT04456426 -
Characteristics of Patients With COVID-19 in Meta State, Colombia
|
||
Terminated |
NCT04435457 -
Cardiovascular Implications of COVID-19
|
||
Suspended |
NCT04385771 -
Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation
|
N/A | |
Withdrawn |
NCT04386447 -
Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19
|
Phase 2 | |
Completed |
NCT04357834 -
WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories
|
||
Completed |
NCT04405934 -
COG-UK Project Hospital-Onset COVID-19 Infections Study
|
N/A | |
Completed |
NCT04615936 -
Nasal Photodisinfection COVID-19 Proof of Concept Study
|
N/A | |
Completed |
NCT04369794 -
COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement
|
Phase 4 | |
Terminated |
NCT04401410 -
Anti-SARS Cov-2 T Cell Infusions for COVID 19
|
Phase 1 | |
Completed |
NCT04542850 -
Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19
|
N/A | |
Completed |
NCT04382040 -
A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19
|
Phase 2 | |
Completed |
NCT04378582 -
Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU
|
||
Completed |
NCT04366908 -
Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome
|
Phase 2 | |
Completed |
NCT04383587 -
Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers
|
N/A | |
Recruiting |
NCT04402814 -
IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.
|
||
Completed |
NCT04425889 -
COVID-19 Antibodies Among Healthcare Workers
|
||
Completed |
NCT04395924 -
Maternal-foetal Transmission of SARS-Cov-2
|
||
Completed |
NCT04374565 -
Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia
|
Phase 2 | |
Not yet recruiting |
NCT04405492 -
Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19
|
N/A |